Back
Madrigal Pharmaceuticals Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
MDGL
Madrigal Pharmaceuticals
Last Price:
$316.00
Seasonality Move:
7.5%
7 Day Trial
ALL ACCESS PASS
$
7

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Madrigal Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 37.3% based on the past 18 years of stock performance.
-
Madrigal Pharmaceuticals has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Madrigal Pharmaceuticals Stock Undervalued?The current Madrigal Pharmaceuticals [MDGL] share price is $307.35. The Score for MDGL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Madrigal Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Madrigal Pharmaceuticals has on average historically risen by 37.3% based on the past 18 years of stock performance.
Madrigal Pharmaceuticals Stock Rating
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals overpriced?
-
Madrigal Pharmaceuticals has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Madrigal Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com
52-Week Data
52-Week High:
377.46
52-Week Low:
189.00
Prediction Charts
Market Cap:
6.8B
Price in USD:
307.35
Volume:
385.2K
Beta:
1.11
Technical Analysis
SMA50:
332.38
SMA100:
323.17
SMA200:
288.58
52-Wk Change:
25.62%
Stock Predictions
-
Is Madrigal Pharmaceuticals stock public?Yes, Madrigal Pharmaceuticals is a publicly traded company.
-
What is the Madrigal Pharmaceuticals stock quote today?The Madrigal Pharmaceuticals stock price is 307.35 USD today.
-
How to buy Madrigal Pharmaceuticals stock online?You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-24 | 343.91 | 346.40 | 346.93 | 338.23 |
Mar-25 | 346.99 | 343.29 | 350.50 | 335.50 |
Mar-26 | 342.71 | 333.82 | 343.41 | 330.73 |
Mar-27 | 333.24 | 337.27 | 338.44 | 331.67 |
Mar-28 | 336.79 | 327.87 | 336.79 | 324.02 |
Mar-31 | 317.62 | 331.23 | 333.00 | 310.00 |
Apr-1 | 331.76 | 323.98 | 334.93 | 320.70 |
Apr-2 | 321.75 | 334.60 | 341.91 | 318.32 |
Apr-3 | 321.19 | 327.10 | 335.29 | 320.00 |
Apr-4 | 318.69 | 314.39 | 325.09 | 309.00 |
Apr-7 | 299.35 | 310.52 | 321.59 | 290.50 |
Apr-8 | 323.64 | 302.78 | 325.81 | 300.22 |
Apr-9 | 296.25 | 313.95 | 333.32 | 289.99 |
Apr-10 | 306.43 | 307.35 | 313.00 | 294.00 |
Madrigal Pharmaceuticals Earnings
Madrigal Pharmaceuticals Earnings Report: Per Share Madrigal Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Madrigal Pharmaceuticals Forecast Revenue Growth
Madrigal Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $2.18 per share, an increase this year of $11.06 per share, and an increase next year of $14.15 per share.
* Madrigal Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.